In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival

被引：0
|
作者：
Tran, Alexandre [1 ]
Rochwerg, Bram [2 ]
机构：
[1] Univ Ottawa, Ottawa, ON, Canada
[2] McMaster Univ, Hamilton, ON, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 10期
关键词：
D O I：
10.7326/J22-0074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC115 / JC115
页数：1
相关论文
共 50 条
  • [1] Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
    Andre C Kalil
    [J]. 四川生理科学杂志, 2020, 42 (04) : 451 - 451
  • [2] Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
    Kalil, A. C.
    Patterson, T. F.
    Mehta, A. K.
    Tomashek, K. M.
    Wolfe, C. R.
    Ghazaryan, V.
    Marconi, V. C.
    Ruiz-Palacios, G. M.
    Hsieh, L.
    Kline, S.
    Tapson, V.
    Iovine, N. M.
    Jain, M. K.
    Sweeney, D. A.
    El Sahly, H. M.
    Branche, A. R.
    Pineda, J. Regalado
    Lye, D. C.
    Sandkovsky, U.
    Luetkemeyer, A. F.
    Cohen, S. H.
    Finberg, R. W.
    Jackson, P. E. H.
    Taiwo, B.
    Paules, C. I.
    Arguinchona, H.
    Erdmann, N.
    Ahuja, N.
    Frank, M.
    Oh, M.
    Kim, E. -S.
    Tan, S. Y.
    Mularski, R. A.
    Nielsen, H.
    Ponce, P. O.
    Taylor, B. S.
    Larson, L. A.
    Rouphael, N. G.
    Saklawi, Y.
    Cantos, V. D.
    Ko, E. R.
    Engemann, J. J.
    Amin, A. N.
    Watanabe, M.
    Billings, J.
    Elie, M. -C.
    Davey, R. T.
    Burgess, T. H.
    Ferreira, J.
    Green, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 795 - 807
  • [3] THE EFFICACY OF REMDESIVIR WITH DEXAMETHASONE VS. DEXAMETHASONE ALONE IN ADULTS HOSPITALIZED WITH COVID-19: A RETROSPECTIVE COHORT STUDY
    Al-Mistarehi, Abdel-Hameed
    Ata, Ehab M. Bani
    Mashina, Marwan M. M.
    Alghzawi, Fadi
    Khassawneh, Ahmad B.
    Ibnian, Ali M.
    Alaabdin, Anas M. Zein
    Jadallah, Abdullah A.
    Alomari, Safwan
    Al Sbihi, Ali
    Kheirallah, Khalid A.
    Alzoubi, Abdallah
    Khassawneh, Basheer Y.
    [J]. CHEST, 2022, 162 (04) : 657A - 658A
  • [4] In adults hospitalized with COVID-19, adding remdesivir to standard care did not reduce in-hospital mortality
    Singh, Kasha P.
    Tong, Steven Y. C.
    [J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (05) : JC51 - JC51
  • [5] Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study
    Yasuda, Yuto
    Hirayama, Yutaka
    Uemasu, Kiyoshi
    Arasawa, Soichi
    Iwashima, Daisuke
    Takahashi, Ken-Ichi
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2022, 81
  • [6] A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
    Ngo, Dallis Q.
    Hamid, Kewan
    Rana, Haris
    Cardinale, Maria
    Frenia, Douglas
    Ghani, Nabil
    Redel, Henry
    [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [7] Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
    Vitiello, Antonio
    Ferrara, Francesco
    [J]. MOLECULAR BIOLOGY REPORTS, 2022, 49 (01) : 827 - 831
  • [8] Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
    Antonio Vitiello
    Francesco Ferrara
    [J]. Molecular Biology Reports, 2022, 49 : 827 - 831
  • [9] Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
    Izumo, Takehiro
    Kuse, Naoyuki
    Awano, Nobuyasu
    Tone, Mari
    Sakamoto, Keita
    Takada, Kohei
    Muto, Yutaka
    Fujimoto, Kazushi
    Saiki, Ayae
    Ito, Yu
    Matsumoto, Haruko
    Inomata, Minoru
    [J]. RESPIRATORY INVESTIGATION, 2021, 59 (06) : 799 - 803
  • [10] Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study
    Gressens, Simon B.
    Esnault, Violaine
    De Castro, Nathalie
    Sellier, Pierre
    Sene, Damien
    Chantelot, Louise
    Hervier, Baptiste
    Delaugerre, Constance
    Chevret, Sylvie
    Molina, Jean-Michel
    [J]. PLOS ONE, 2022, 17 (02):
12345